Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Dermatol Venereol Leprol ; 2012 May-Jun; 78(3): 407
Article Dans Anglais | IMSEAR | ID: sea-141112

Résumé

Sneddon syndrome (SS) is rare, arterio-occlusive disorder characterized by generalized livedo racemosa of the skin and various central nervous symptoms due to occlusion of medium-sized arteries of unknown. Seizure, cognitive impairment, hypertension, and history of repetitive miscarriages are the other symptoms seen in this disease. Livedo racemosa involves persisting irreversible skin lesions red or blue in color with irregular margins. Usually, SS occurs in women of childbearing age. Protein S deficiency is an inherited or acquired disorder associated with an increased risk of thrombosis. We present a 33-year-old woman with SS with diffuse livedo racemosa, recurrent cerebrovascular diseases, migraine-type headache, sinus vein thrombosis, and protein S deficiency. Protein S deficiency and with Sneddon syndrome rarely encountered in the literature.

2.
Indian J Pediatr ; 2010 June; 77(6): 681-683
Article Dans Anglais | IMSEAR | ID: sea-142606

Résumé

Four children with vincristine (VCR)-induced neuropathy are being reported. All cases were followed with the diagnosis of acute lymphoblastic leukemia. Two were boys aged between 2 and 13 year. Electromyographic examination consisted of sensoriomotor polyneuropathy with axonal involvement in three patients. In another patient, it consisted of motor axonal polyneuropathy. In all patients, pyridoxine and pyridostigmine were successfully used in the treatment of VCR-induced neuropathy. They recovered completely with this drug combination. Recovering period of symptoms was between 1-2 week.


Sujets)
Adolescent , Antinéoplasiques d'origine végétale/administration et posologie , Antinéoplasiques d'origine végétale/effets indésirables , Enfant , Enfant d'âge préscolaire , Anticholinestérasiques/usage thérapeutique , Association de médicaments , Femelle , Humains , Mâle , Polyneuropathies/induit chimiquement , Polyneuropathies/diagnostic , Polyneuropathies/traitement médicamenteux , Leucémie-lymphome lymphoblastique à précurseurs B et T/diagnostic , Leucémie-lymphome lymphoblastique à précurseurs B et T/traitement médicamenteux , Bromure de pyridostigmine/usage thérapeutique , Pyridoxine/usage thérapeutique , Résultat thérapeutique , Vincristine/administration et posologie , Vincristine/effets indésirables , Complexe vitaminique B/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche